First Horizon Advisors Inc. Has $26,000 Position in Simulations Plus, Inc. (NASDAQ:SLP)

First Horizon Advisors Inc. increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 82.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 818 shares of the technology company’s stock after acquiring an additional 370 shares during the quarter. First Horizon Advisors Inc.’s holdings in Simulations Plus were worth $26,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SLP. Public Employees Retirement System of Ohio acquired a new position in shares of Simulations Plus during the first quarter worth approximately $1,082,000. Silvercrest Asset Management Group LLC bought a new stake in Simulations Plus during the 1st quarter valued at $4,717,000. Deerfield Management Company L.P. Series C acquired a new position in Simulations Plus during the second quarter worth $811,000. US Bancorp DE lifted its stake in shares of Simulations Plus by 37.0% in the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after buying an additional 1,343 shares in the last quarter. Finally, Royce & Associates LP grew its holdings in shares of Simulations Plus by 28.8% during the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after buying an additional 53,092 shares during the last quarter. 78.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

SLP has been the topic of several recent research reports. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. Stephens began coverage on Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price on the stock. William Blair restated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. BTIG Research reduced their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Finally, KeyCorp assumed coverage on shares of Simulations Plus in a report on Monday, July 29th. They issued an “overweight” rating and a $47.00 target price for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Simulations Plus presently has an average rating of “Moderate Buy” and an average price target of $51.40.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the transaction, the director now owns 3,462,584 shares in the company, valued at $95,775,073.44. This trade represents a 0.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 60,750 shares of company stock valued at $1,905,655 over the last ninety days. 20.90% of the stock is currently owned by insiders.

Simulations Plus Price Performance

NASDAQ SLP opened at $32.74 on Tuesday. The stock has a market capitalization of $656.99 million, a price-to-earnings ratio of 66.82 and a beta of 0.71. The business’s fifty day moving average is $30.80 and its 200-day moving average is $38.17. Simulations Plus, Inc. has a one year low of $27.07 and a one year high of $51.22.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. During the same period in the previous year, the company earned $0.18 earnings per share. The company’s quarterly revenue was up 19.9% on a year-over-year basis. Research analysts expect that Simulations Plus, Inc. will post 1.12 EPS for the current fiscal year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.